The majority of basal-like breast cancers lack the expression of ER, PR, and HER-2, in a subtype called triple negative breast cancer (TNBC), which accounts for 11.2% of breast cancers, is prevalent in young woman, and often relapses rapidly with poor prognosis [6]. Here, ERBB2 is linked to breast carcinoma.